Induced pluripotent stem cell (iPSC)-derived cortical neurons are increasingly 26 used as a model to study developmental aspects of Autism Spectrum Disorder 27 (ASD), which is clinically and genetically heterogeneous. To study the complex 28 relationship of rare (penetrant) variant(s) and common (weaker) polygenic risk 29 variant(s) to ASD, "isogenic" iPSC-derived neurons from probands and family-30 based controls, for modeling, is critical. We developed a standardized set of 31 procedures, designed to control for heterogeneity in reprogramming and 32 differentiation, and generated 53 different iPSC-derived glutamatergic neuronal 33 lines from 25 participants from 12 unrelated families with ASD (14 ASD-affected 34 individuals, 3 unaffected siblings, 8 unaffected parents). Heterozygous de novo 35 (7 families; 16p11.2, NRXN1, DLGAP2, CAPRIN1, VIP, ANOS1, THRA) and 36 rare-inherited (2 families; CNTN5, AGBL4) presumed-damaging variants were 37 characterized in ASD risk genes/loci. In three additional families, functional 38 candidates for ASD (SET), and combinations of putative etiologic variants 39 (GLI3/KIF21A and EHMT2/UBE2I combinations in separate families), were 40 modeled. We used a large-scale multi-electrode array (MEA) as our primary high-41 throughput phenotyping assay, followed by patch clamp recordings. Our most 42
Introduction 48
The past two decades of research has determined Autism Spectrum Disorders 49 (ASD) to be clinically (Fernandez and Scherer, 2017 specified into the single grouping of ASD (DSM-V, 2013). There are also 56 syndromic forms of ASD (Carter and Scherer, 2013) , and now more than 100 57 other disorders carrying different names (Betancur, 2011) , that in a proportion of 58 subjects can also present the necessary symptoms for an ASD diagnosis. 59 60 From the perspective of genetics, heritability estimates and family studies 61 definitely demonstrate genes to be involved (Ronald and Hoekstra, 2011) . Single 62 high-penetrance genes and copy number variation (CNV)-affected loci, have now 63 been implicated as bona fide autism-susceptibility (or risk) genes, although none 64 Table 1 ; corresponding genomic coordinates in Table S1 ). Typically, one 141 proband and one sex-matched unaffected member (control) per family were 142 included (Figure 1) . In total, 14 probands and 11 controls participated, of which 143 21 were males and 4 were females (Figure 1 and Table 1 ). Cells from either skin 144 fibroblasts or CD34+ blood cells were collected for reprogramming into iPSCs 145 (Figure 2A and Table 1) . 146
Derivation of iPSC Lines

147
Two different viral approaches were used for cell reprogramming. For historical 148 reasons, the first two lines in Table 1 , namely 19-2 and NR3, were 149 reprogrammed using retroviruses expressing OCT4/POU5F1, SOX2, KLF4 and 150 MYC, and a lentiviral vector that encoded the pluripotency reporter EOS-151 GFP/Puro R (Hotta et al., 2009 ). Then, we moved to non-integrative Sendai virus 152 for all the other tested lines ( Table 1) . Emerging iPSC colonies were selected for 153 activated endogenous human pluripotency markers, differentiation potential into 154 three germ layer cells after embryoid body formation in vitro, and normal 155 karyotype ( Figure 2B-D and Table S2 ). Two separate pluripotent and 156 karyotypically normal iPSC lines were typically selected per participant for 157 neuronal differentiation and phenotyping experiments ( Table 1) . 158
Transient Induction of Neuronal Differentiation
159
We induced differentiation of newly generated iPSCs into glutamatergic neurons 160 to test their electrophysiological properties (Figure 2A) . We used the NEUROG2 161 ectopic expression approach since highly-enriched populations of glutamatergic 162 neurons can be obtained within a week, and they exhibit robust synaptic activity 163 when co-cultured with glial cells (Zhang et al., 2013) . Importantly, we determined 164 that this strategy offers highly uniform differentiation levels between cell lines 165 derived from different participants (Deneault et al., 2018) . This consistency was 166 necessary to perform suitable phenotyping assays such as network 167 electrophysiology recordings of several different lines in the same experimental 168 batch. The resulting glutamatergic neurons were all subjected to 169 electrophysiological phenotyping. 170
Multi-Electrode Array Analysis of iPSC-Derived Neurons
171
MEA phenotyping was predominantly used in order to monitor the excitability of 172 several independent cultured neuron populations in parallel, and in an unbiased 173 manner. We sought to determine if any selected ASD-risk variants would 174 interfere with spontaneous spiking and synchronized bursting activity in a whole 175 network of interconnected glutamatergic neurons. We ensured that the duration 176 and amplitude of detected spikes were similar to typical mammalian neurons, i.e., 177 action potential widths of around 1-2 milliseconds (ms) and peak amplitudes of 178 approximately 20-150 µV (Figure S1A) . We monitored the weighted mean firing 179 rate (MFR), which represents the MFR per active electrode, four to eight weeks 180 post-NEUROG2 induction (PNI), in all control cells, i.e., all unaffected sex-181
matched family members from all tested families. After pooling all control 182 samples together, the highest MFR was observed at week six PNI (Figure S1A , 183 right panel). Hence, we opted to use week six PNI as the common reading time 184 point for comparison of all cell lines. 185
186
We measured the glutamatergic/GABAergic nature of our cultured neurons 187 produced using NEUROG2 ectopic expression, which is known to repress 188 Table 1) . For this reason, we averaged the 249 results obtained from all unrelated controls used in this study, compared it with 250 line NR3, and obtained no significant differences (Figure S2A) . Although a 251
proper genetically-matched control was not available for line NR3, this suggests 252 that the loss of one NRXN1 allele does not interfere with control neuronal activity 253 in this setting. 254
Repair of ANOS1 Rescues Defective Membrane Currents
255
In a complementary approach to minimize the confounding effects of genetic 256 background from familial and unrelated controls, and its impact on phenotype, we 257 sought to edit our proband-specific variants using CRISPR in order to create 258 matching isogenic controls. We prioritized genes affected by nonsense variants 259 such as CAPRIN1, VIP and ANOS1 (Figure 1F-H and Table 1 ). For instance, 260 the nonsense variant R423X found in ANOS1 in participant 2-1303-003 was 261 successfully corrected in the corresponding iPSC line 18C (Figure 4A-C) . 262
Indeed, after detecting 7% edited cells using droplet digital PCR (ddPCR) in well 263 G08 in the primary 96-well culture plate post-nucleofection, two subsequent 264 limiting-dilution enrichment steps were necessary to isolate a 100% corrected 265 iPSC line ( Figure 4B) . Sanger sequencing confirmed the properly corrected 266 genomic DNA sequence (Figure 4C ). This newly corrected line was named 267 "18CW" (see iPSC line ID "18CW" in Table 1 and Figure 4C ). 268 13 269 Despite a behaviour similar to the unaffected familial control line 19A in terms of 270 weighted MFR and network burst frequency, the CRISPR-corrected line 18CW 271 did not exhibit a statistical difference from to its isogenic counterpart 18C ( Figure  272   S2D) . Nonetheless, the availability of such isogenic set prompted us to explore 273 more detailed electrophysiological properties using patch-clamp recordings of 274 single neurons in order to reveal any phenotype not detected using MEA. While 275 the advantage of MEA experiments is that continuous live monitoring of neural 276 activity can be measured over multiple weeks, we used patch-clamp 277 electrophysiology on NEUROG2 neurons between days 21-25 PNI. This time 278 window provides robust recordings to detect phenotypes, as shown in previous 279 studies (Yi et al., 2016) . Furthermore, the increased density of neuronal 280 processes appearing beyond 4 weeks PNI can preclude consistent clean patch-281 clamp recordings, but this is not an issue with MEA. Using this protocol, we 282 detected significantly lower outward membrane current at 40 mV in the mutant 283 line 18C compared to its isogenic control 18CW (Figure 4D Notably, these observations underline that some specific electrophysiological 292 phenotypes at the single cell level, e.g., membrane currents, may not be 293 captured when using MEA monitoring at the cell population level. 294
Addressing Complex-Variant Lines
295
Studying the relationship between ASD in individuals carrying multiple ASD-296 relevant variants requires additional considerations. For example, lines 36O and 297 36P were reprogrammed from participant 7-0058-003 and were each carrying a 298 323-kb deletion disrupting AGBL4, a 243-kb deletion disrupting TCERG1L, and a 299 516-kb duplication encompassing the GPR148, AMER3, ARHGEF4, FAM168B, 300 POTEE genes ( Figure 1E and Table 1 ). As for line NR3, no unaffected family 301 member was available as control for lines 36O and 36P, thus we used the "all 302 Table 1 ). MEA recordings between weeks 4-8 PNI showed a significantly 313 higher weighted MFR and network burst frequency compared to their familial 314 control line 37E (Figure 5A ). To ensure that this hyperactivity was synaptic and 315 not only intrinsic to the neurons, we performed patch-clamp recordings, at day 316 21-25 PNI to avoid the increased density of neuronal processes that impacts the 317 ability to obtain clean recordings, as stated previously. Intrinsic properties, e.g., 318
capacitance and resistance, did not vary significantly (Figure 5B) , indicating 319 comparable maturity levels between lines 37E and 38E. While spontaneous 320 excitatory post-synaptic current (sEPSC) amplitude was unchanged, sEPSC 321 frequency was significantly higher in mutant neurons compared to controls 322 ( Figure 5B) . These observations suggest that a potential loss-of-function of 323 UBE2I and/or EHMT2 is involved in ASD-related neuronal dysfunction. 324
Evidence of Functional Impact of EHMT2, but not UBE2l Variants
325
Since our attempts to edit the variants E78K in UBE2I and K1164Nfs in EHMT2 326 had not been successful, we sought to determine the potential contribution of 327 E78K in UBE2I to the observed synaptic hyperactivity. To estimate the damaging 328 potential of this missense variant on the function of UBE2I protein, we utilized a 329
Saccharomyces cerevisiae complementation assay that was previously 330 developed as a validated surrogate genetic system to predict the pathogenicity of 331 diverse human variants (Sun et al., 2016) . In this assay, lethality of a 332 temperature-sensitive allele of the yeast UBC9 gene (ortholog of human UBE2I) 333 is rescued by expressing a functional version of human UBE2I. Several missense 334 variants in UBE2I have been accurately predicted as deleterious at conserved 335 positions, or benign at other positions (Zhang et al., 2017) . Therefore, we used 336 this complementation assay to test the consequence of our variant E78K, and 337 found no effect of this variant on the function of human UBE2I (Figure S4) . 338
Because these results disfavor involvement of the UBE2I variant E78K in the 339 neuronal hyperactivity observed in Figure 5A This suggests that a reduced expression of EHMT2 increases spontaneous 346 spiking activity and sEPSC frequency of glutamatergic neurons. 347
EHMT2 -/+ CRISPR-Isogenic Pair Confirms Neuronal Hyperactivity
348
Since the prediction of damage extent of the frameshift variant K1164Nfs on the 349 function of EHMT2 may not be accurate, we used our StopTag insertion strategy 350 in iPSC line 19-2, and targeted exon 20 of the transcript ENST00000375537.8 of 351 EHMT2 in order to disrupt its expression. In this new isogenic line, weighted MFR 352 and network burst frequency were also significantly increased in iPSC-derived 353 19-2-EHMT2 StopTag/+ neurons compared to control 19-2, around week 9 PNI and 354 beyond ( Figure 5D ). This increased activity in mutant neurons occurred later 355 than that observed in the familial lines 38B/E, possibly due to different genetic 356 backgrounds. Accordingly, EHMT2 protein levels were reduced by half in mutant 357 cells ( Figure 5E ). We also performed patch-clamp recordings on these neurons 358 at day 21-25 PNI, as above. We did not detect any significant change in sEPSC 359 frequency and amplitude at this earlier time point compared to the MEA 360 experiment. However, intrinsic properties showed a significant increase in 361 capacitance and a lower resting membrane potential in mutant cells (Figure S5) . 362
These observations suggest that the mutant neurons at 3-4 weeks PNI potentially 363 have a faster maturation rate, however this phenotype is most pronounced in the 364 hyperactivity recorded by MEAs later at 9-11 weeks PNI.These results support 365 the conclusion that inactivation of one allele of EHMT2 significantly increases 366 spontaneous network activity of excitatory neurons, with possible effects on the 367 neuronal maturation process. individual variation. We derived two independent iPSC clones per participants to 395 regulate intra-individual variation. Another important parameter to consider is the 396 cellular homogeneity of neuronal cultures. We preferred to use the NEUROG2 397 system over classic dual-SMAD inhibition protocols because we believe it 398 represents an advantage in terms of cellular homogeneity. It is also much faster 399 than classic protocols and produces much higher proportion of glutamatergic 400 neurons that can be studied for ASD (Canitano and Pallagrosi, 2017 obtain isogenic controls may be challenging due to the size, but this approach 467 might eventually be applied. 468
469
Using a yeast complementation assay (Figure S4) , we estimated the missense 470 variant E78K in UBE3I not responsible for the electrophysiological phenotypes 471 observed in participant 6-0393-003 (Figure 5A-B) . These results prompted us to 472 investigate further on the potential role of the frameshift variant K1164Nfs in 473 EHMT2. EHMT2 (G9a) is a histone methyltransferase (HMTase) that forms a 474 complex with EHMT1 (GLP) to catalyze mono-and dimethylation of lysine 9 on 475 histone H3 (H3K9me1/2) (Rice et al., 2003) . Of note, EHMT1 protein sequence is 476 Oversight Committee, all iPSCs were generated from dermal fibroblasts or 517 CD34+ blood cells. Skin-punch biopsies were obtained from the upper back area 518 by a clinician at The Hospital for Sick Children. Samples were immersed in 14 ml 519 of ice-cold Alpha-MEM (Wisent Bioproducts) supplemented with penicillin 100 520 Units/ml and streptomycin 100 μg/ml (ThermoFisher), and transferred 521 immediately to the laboratory at The Centre for Applied Genomics (TCAG). Each 522 biopsy was cut into ~1mm 3 pieces with disposable scalpel in a 60-mm dish. 5 ml 523 of collagenase 1 mg/ml (Sigma, Canada) was added and the dish was placed in 524 37°C incubator for 1:45 hours. Skin pieces and collagenase were then 525 transferred to a 15-ml tube, and centrifuged at 300 g for 10 minutes. Supernatant 526 was removed, 5 ml of trypsin 0.05%/EDTA 0.53 mM (Wisent Bioproducts) was 527 added, and the mix was pipetted up and down several times to break up tissue 528 and placed in 37°C incubator for 30 minutes. After incubation, the mix was 529 centrifuged at 300 g for 10 minutes, and supernatant was removed leaving 1 ml. 530
The pellet was pipetted up and down vigorously to break to the pieces without 531 creating bubbles. The mix was transferred in a T-12.5 flask along with 5 ml of 532
Alpha-MEM, 15% Fetal Bovine Serum (FBS; Wisent Bioproducts), penicillin 100 533
Units/ml and streptomycin 100 μg/ml (ThermoFisher), and placed in 37°C 534 incubator for about a week until 100% confluence. Cultured cells were fed every 535 5-7 days if not confluent. Once confluent, cells were passed into three 100 mm 536 dishes to expand, and frozen in liquid nitrogen. 537
Reprogramming Fibroblasts Using Integrative Virus
538
Reprogramming of skin fibroblasts was performed using retroviral and lentiviral 539 vectors. Retroviral vectors encoding POU5F1, SOX2, KLF4, MYC, and lentiviral 540 vectors encoding the pluripotency reporter EOS-GFP/Puro R were used and 541 obtained as described (Hotta et al., 2009) . 542
Reprogramming Fibroblasts Using Non-Integrative Sendai Virus
543
Reprogramming of fibroblasts via Sendai virus was performed at the Centre for 544 
Gene Editing
597
For point mutation correction in 18C line, we used the type II CRISPR/Cas9 598 double-nicking (Cas9D10A) system with two guide RNA (gRNAs) to reduce off-599 target activity. We devised the gRNA sequences using tools available at 600 http://crispr.mit.edu/. We designed a HDR-based method using a synthesized 601 single-stranded oligonucleotide (ssODN) template to replace the point mutation 602
with the reference nucleotide. To prevent damage to the correct sequence, a 603 silent mutation was introduced in the ssODN close to the proto-adjacent motif 604 (PAM) of the reverse gRNA (gRNA-), which commands Cas9D10A to nick the 605 plus strand, given that ssODN was synthesized as plus strand. All the CRISPR 606 (Zhang et al., 2013) . Next day, the 622 media was changed. The day after that, the media was spun down in a high-623
speed centrifuge at 30,000 g at 4°C for 2 hours. The supernatant was discarded 624 and 50 μl PBS was added to the pellet and left overnight at 4°C. The next day, 625 the solution was triturated, aliquoted and frozen at -80°C. 626
Differentiation into Glutamatergic Neurons
627
5x10 5 iPSCs/well were seeded in a matrigel-coated 6-well plate in 2 ml of mTeSR 628 supplemented with 10 μM Y-27632. Next day, media in each well was replaced 629 29 with 2 ml fresh media plus 10 μM Y-27632, 0.8 μg/ml polybrene (Sigma), and the 630 minimal amount of NEUROG2 and rtTA lentiviruses necessary to generate 100% 631 GFP+ cells upon doxycycline induction, depending on prior titration of a given 632 virus batch. The day after, virus-containing media were replaced with fresh 633 mTeSR, and cells were expanded until near-confluency. Newly generated 634 "NEUROG2-iPSCs" were detached using accutase, and seeded in a new 635 matrigel-coated 6-well plate at a density of 5x10 5 cells per well in 2 ml of mTeSR 636 supplemented with 10 μM Y-27632 (day 0 of differentiation). Next day (day 1), 637 media in each well was changed for 2 ml of CM1 [DMEM-F12 (Gibco), 1x N2 638 (Gibco), 1x NEAA (Gibco), 1x pen/strep (Gibco), laminin (1 μg/ml; Sigma), BDNF 639 (10 ng/μl; Peprotech) and GDNF (10 ng/μl; Peprotech) supplemented with fresh 640 doxycycline hyclate (2 μg/ml; Sigma) and 10 μM Y-27632. The day after (day 2), 641 media was replaced with 2 ml of CM2 [Neurobasal media (Gibco), 1x B27 642 (Gibco), 1x glutamax (Gibco), 1x pen/strep, laminin (1 μg/ml), BDNF (10 ng/μl) 643 and GDNF (10 ng/μl)] supplemented with fresh doxycycline hyclate (2 μg/ml) and 644 puromycin (5 μg/ml for 19-2-derived cells, and 2 μg/ml for 50B-derived cells; 645 Sigma). Media was replaced with CM2 supplemented with fresh doxycycline 646 hyclate (2 μg/ml). The same media change was repeated at day 4. At day 6, 647 media was replaced with CM2 supplemented with fresh doxycycline hyclate (2 648 μg/ml) and araC (10 μM; Sigma). Two days later, these day 8 post-NEUROG2-649 induction (PNI) neurons were detached using accutase and ready to seed for 650 subsequent experiments, as described below. 651
Multi-electrode array (MEA) 652
48-well opaque-bottom MEA plates (Axion Biosystems) were coated with filter-653 sterilized 0.1% polyethyleneimine solution in borate buffer pH 8.4 for 1 hour at 654 room temperature, washed four times with water, and dried overnight. 120,000 655 "day8-dox" neurons/well were seeded in 250 μl CM2 media. The day after, 5,000 656 mouse astrocytes/well were seeded on top of neurons in 50 μl/well CM2 media. 657
Astrocytes were prepared from postnatal day 1 CD-1 mice as described (Kim and 658 Magrane, 2011). Media was half-changed once a week with CM2 media. Every 659
week post-seeding, the electrical activity of the MEA plates was recorded using 660 the Axion Maestro MEA reader (Axion Biosystems). The heater control was set to 661 warm up the reader at 37°C. Each plate was first incubated for 5 minutes on the 662 pre-warmed reader, then real-time spontaneous neural activity was recorded for 663 5 minutes using AxIS 2.0 software (Axion Biosystems). A bandpass filter from 664 200 Hz to 3 kHz was applied. Spikes were detected using a threshold of 6 times 665 the standard deviation of noise signal on electrodes. 666
Offline advanced metrics were re-recorded and analysed using Axion Biosystems 667 Neural Metric Tool. An electrode was considered active if at least 5 spikes were 668 detected per minute. Single electrode bursts were identified as a minimum of 5 669 spikes with a maximum interspike interval (ISI) of 100 milliseconds. Network 670 bursts were identified as a minimum of 10 spikes with a maximum ISI of 100 671 milliseconds covered by at least 25% of electrodes in each well. No non-active 672 well was excluded in the analysis. After the last reading, each well was treated 673 with three synaptic antagonists: GABA A receptor antagonist picrotoxin (PTX; 674 Sigma) at 100 μM, AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-675 dion (CNQX; Sigma) at 60 μM, and sodium ion channel antagonist tetrodotoxin 676 (TTX; Alomone labs) at 1 μM. The plates were recorded consecutively, 5-10 677 minutes after addition of the antagonists. A 60-minute recovery period was 678 allowed in the incubator at 37°C between each antagonist treatment and plate 679 recording. 680
Patch-Clamp Recordings
681
Day 3 PNI neurons were replated at a density of 100 000/well of a poly-682 ornithin/laminin coated coverslips in a 24-well plate with CM2 media. On day 4, 683 50 000 mouse astrocytes were added to the plates and cultured until day 21-28 684 PNI for recording. At day 10, CM2 was supplemented with 2.5% FBS in 685 accordance with (Zhang et al., 2013) . Whole-cell recordings (BX51WI; Olympus) 686 were performed at room temperature using an Axoclamp 700B amplifier 687 (Molecular Devices) from borosilicate patch electrodes (P-97 puller; Sutter 688 Instruments) containing a potassium-based intracellular solution (in mM): 123 K-689 gluconate, 10 KCL, 10 HEPES; 1 EGTA, 2 MgCl 2 , 0.1 CaCl 2 , 1 Mg -ATP, and 0.2 690 Na 4 GTP (pH 7.2). 0.06% sulpharhodamine dye was added to select neurons for 691 visual confirmation of multipolar neurons. Composition of extracellular solution 692 was (in mM): 140 NaCl, 2.5 KCl, 1 1.25 NaH 2 PO 4 , 1 MgCl 2 , 10 glucose, and 2 693 CaCl 2 (pH 7.4). Whole cell recordings were clamped at −70 mV using Clampex 694 10.6 (Molecular Devices), corrected for a calculated −10 mV junction potential 695 and analyzed using the Template Search function from Clampfit 10.6 (Molecular 696 Devices). Following initial breakthrough and current stabilization in voltage clamp, 697 the cell was switched to current clamp to monitor initial spiking activity and record 698 the membrane potential (cc=0, ~1 min post-breakthrough). Bias current was 699 applied to bring the cell to ~70 mV whereby increasing 5 pA current steps were 700 applied (starting at -20 pA) to generate the whole cell resistance and to elicit 701 action potentials. Data were digitized at 10 kHz and low-pass filtered at 2 kHz. 702
Inward and outward currents were recorded in whole-cell voltage clamp in 703 response to consecutive 10 mV steps from -90 mV to +40 mV. 704
Yeast Complementation Assay
705
The method for the yeast complementation assay was described previously (Sun 706 et al., 2016) . 707
Antibodies and Western Blotting
708
Cells were washed in ice-cold PBS and total protein was extracted in RIPA 709 supplemented with proteinase inhibitor cocktail, and homogenized. Equivalent 710 protein mass was loaded on gradient SDS-PAGE (4-12%) and transferred to 711
Nitrocellulose membrane Hybond ECL (GE HealthCare). Primary antibodies used 712 were rabbit anti-CNTN5 (Novus, NBP1-83243) and rabbit anti-EHMT2/G9A 713 (Abcam, ab185050). HRP-conjugated secondary antibodies (Invitrogen) were 714 used and the membranes were developed with SuperSignal West Pico 715 Chemiluminescent Substrate (Pierce). Images acquired using ChemiDoc MP 716 (BioRad) and quantified using software Imagelab v4.1 (BioRad). Western Blots 717 were repeated at least twice for each biological replicate. 718
All cell lines were regularly tested for presence of mycoplasma using a standard 720 method (Otto, 1996) Table S1 . Table 1 List of participants with ASD or unaffected controls, with the genetic variant(s) involved, and the different iPSC lines derived. Figure 1 Genetic pedigrees of the participant families with identified genetic variants. One proband (black arrow) and one gender-matched unaffected member (black star) were typically selected for iPSC reprogramming. ASD-affected children are represented with a black box; note that line 1-0019-002 (19-2) in A) was used as a control and was described previously ( Figure 3 Multi-electrode array monitoring of iPSC-derived glutamatergic neurons. Weighted mean ring rate (MFR) and network burst frequency were recorded from (A) CNTN5 family at week 6 PNI, (B) CNTN5-isogenic pair 19-2 from week 4-11 PNI, and (C) THRA family NEUROG2-neurons at week 6 PNI; weighted MFR represents the MFR per active electrode; an electrode was considered active when a minimum of 5 spikes per minute were detected; a network burst was identi ed as a minimum of 10 spikes with a maximum inter-spike interval of 100 ms, occurring on at least 25% of electrodes per well; iPSC IDs and genotypes are indicated below each graph; values are presented as mean±SEM of two di erent lines per participant, and of several technical and biological replicates, as presented in Table S3 . Right panels show western blots revealing protein levels in mutant and control iPSC-derived neurons; actin beta (ACTB) was used as a loading control and the relative intensity of each band is indicated below the blots. * p < 0.05 from unpaired t test two-tailed (A and C), and from multiple t test comparison (B) Correction of point mutation in ANOS1 in iPSCs using CRISPR editing. (A) Design of gRNAs, ssODNs and ddPCR probes for correction of R423X in ANOS1; one sgRNA for each genomic DNA strand, i.e., gRNA-in blue and gRNA+ in yellow, was devised in close proximity for the double-nicking system using Cas9D10A; the non-sense mutations in ANOS1 is depicted in bold red; a silent mutation was introduced in ssODN (in blue) for ddPCR probe (underlined) speci city and to prevent nicking. (B) ddPCR absolute quanti cation coupled with two consecutive limiting-dilution enrichment steps were necessary to isolate a 100% corrected line, i.e., 100% VIC signal. (C) Sanger sequencing con rmed proper correction of non-sense mutation R423X in line 18C back to wt; this newly corrected line was named 18CW. (D) Outward and inward membrane current detected by patch-clamp recordings; total number of recorded neurons was 15 for both 18C and 18CW, 20 for ANOS1 -/y and 33 for control 19-2; values are presented as mean±SEM of three independent di erentiation experiments, recorded at day 21-25 PNI. * p < 0.05 from multiple t test comparison 
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